Pfizer Inc (PFE)

PFE on New York Consolidated

30.59USD
21 Apr 2014
Price Change (% chg)

$0.34 (+1.12%)
Prev Close
$30.25
Open
$30.54
Day's High
$30.72
Day's Low
$30.40
Volume
5,709,738
Avg. Vol
28,819,041
52-wk High
$32.96
52-wk Low
$27.12

PFE

Chart for PFE

About

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company’s diversified global healthcare portfolio includes human... (more)

Overall

Beta: 0.74
Market Cap (Mil.): $193,404.30
Shares Outstanding (Mil.): 6,393.53
Dividend: 0.26
Yield (%): 3.44

Financials

  PFE Industry Sector
P/E (TTM): 18.33 33.26 33.35
EPS (TTM): 1.65 -- --
ROI: 7.49 19.66 18.92
ROE: 14.45 20.35 19.68
Search Stocks

Wall Street opens flat as earnings deluge looms

NEW YORK - U.S. stocks opened flat on Monday as investors found few reasons to keep buying following a strong rally last week and ahead of a heavy week of corporate earnings.

9:36am EDT

Deals of the day- Mergers and acquisitions

April 21 - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday:

9:30am EDT

US STOCKS-Futures flat as investors await earnings onslaught

* S&P 500 coming off biggest weekly percentage gain since July

8:43am EDT

AstraZeneca cancer pipeline seen as draw for Pfizer

LONDON - Pfizer may come back to bid for British drug company AstraZeneca after its reported 60 billion pound ($101 billion) takeover approach was rejected, since a deal could make sense for the U.S. pharmaceuticals giant as it seeks to build up its cancer franchise.

7:20am EDT

AstraZeneca cancer pipeline seen as draw for Pfizer

LONDON, April 21 - Pfizer may come back to bid for British drug company AstraZeneca after its reported 60 billion pound ($101 billion) takeover approach was rejected, since a deal could make sense for the U.S. pharmaceuticals giant as it seeks to build up its cancer franchise.

6:55am EDT

Pfizer considers $100 billion bid for AstraZeneca: report

LONDON - U.S. pharmaceutical giant Pfizer has approached British rival AstraZeneca to propose a 60 billion pound ($101 billion) takeover, Britain's Sunday Times reported.

20 Apr 2014

UPDATE 1-Pfizer considers $100 bln bid for AstraZeneca - report

LONDON, April 20 - U.S. pharmaceutical giant Pfizer has approached British rival AstraZeneca to propose a 60 billion pound ($101 billion) takeover, Britain's Sunday Times reported.

20 Apr 2014

Pfizer mulls $100 bln bid for AstraZeneca - report

LONDON, April 20 - U.S. pharmaceutical giant Pfizer has approached British rival AstraZeneca to propose a 60 billion pound ($101 billion) takeover, the Sunday Times reported on Sunday.

20 Apr 2014

UPDATE 2-Teva settles patent suit with Pfizer over Celebrex

April 17 - Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc's blockbuster painkiller Celebrex in December.

17 Apr 2014

Teva, Pfizer settle patent lawsuit over blockbuster painkiller

- Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December.

17 Apr 2014

Competitors

  Price Change
The Procter & Gamble Company (PG.N) $81.64 -0.12
Johnson & Johnson (JNJ.N) $99.78 +0.82
Novartis AG (NOVN.VX) CHF74.70 +0.35
Merck & Co., Inc. (MRK.N) $56.75 +0.28
Roche Holding Ltd. (ROG.VX) CHF254.90 +0.70
Abbott Laboratories (ABT.N) $38.64 -0.29
Bayer AG (BAYGn.DE) €93.59 +0.66
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €75.48 +0.71
AstraZeneca plc (AZN.L) 3,781.50p +23.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks